# CKD-828 (80/5mg) Pharmacokinetic Study

> **NCT02358824** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 48 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** CKD-828
- **DRUG:** Telmisartan
- **DRUG:** S-amlodipine

## Key facts

- **NCT ID:** NCT02358824
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-05
- **Final completion:** 2015-06
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2015-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02358824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02358824, "CKD-828 (80/5mg) Pharmacokinetic Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02358824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*